Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation and Reliability of the Turkish Version of the Parent-Reported Drug Hypersensitivity Quality of Life Questionnaire (P-DrHy-Q)

NCT07069439 is registered in ClinicalTrials.gov with Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization as lead sponsor.

NCT NCT07069439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07069439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation and Reliability of the Turkish Version of the Parent-Reported Drug Hypersensitivity Quality of Life Questionnaire (P-DrHy-Q)
Lead sponsor
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Phase
Observational
Overall status
Completed
Start date
August 1, 2025
Completion date
October 30, 2025
Enrollment
74 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergy and immunology, caregivers, drug hypersensitivity, quality of life (qol)